+
Site Tour

Search

Showing 61 - 70 of 449 results.

  • EPIC™ MAX Patients who benefit

    © Abbott 2025. All rights reserved. 9-EH-5-14980-01 02-2025 REV B
  • EPIC™ Plus Features

    Silicone-Filled Cuff FlexFitTM Polymer Stent Unique Pericar
  • Overview

    Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a ca
  • Transcatheter Replacement

    TRANSCATHETER Mitral Valve Replacement (TMVr): To date, TMVR has generally been used in: Surgical high-risk patients. Patients who are not candidates for TMVr as their mitral valve anatomy is n
  • Transcatheter Repair

    Transcatheter edge-to-edge repair (TEER) is a minimally invasive option: Overall, many patients in need of valve reconstruction or replacement do not undergo surgery because of high perioperative ris
  • Diagnosis

    MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be experi
  • Overview

    See Diagnosis AS is a progressive disease. While patients with AS may initially be asymptomatic, further progression is typically associated with symptoms and poor prognosis.13,14 AS is associa
  • Diagnosis

    The three cardinal symptoms of AS are angina, syncope or heart failure (HF).13,16 Other symptoms include dyspnea and decreased exercise tolerance.14 Primary care physicians should consider AS in ad
  • Options

    Treatment options for aortic stenosis: MEDICAL MANAGEMENT Medical treatment options for symptomatic patients with severe AS are limited. Medical treatment may be helpful in ameliorating symptoms in
  • Surgical Replacement

    FIND OUT MORE: Abbott Tissue Heart Valves   Abbott Mechanical Heart Valves

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline